(Q47322291)

14 January 2018

title

Barriers to the long-term use of low-molecular weight heparins for treatment of cancer-associated thrombosis (English)

1 reference

14 January 2018

0 references

Wittkowsky AK

1

1 reference

14 January 2018

publication date

1 September 2006

1 reference

14 January 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

14 January 2018

volume

4

1 reference

14 January 2018

issue

9

1 reference

14 January 2018

page(s)

2090-2091

1 reference

14 January 2018

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02073.X

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02073.X

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02073.X

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02073.X

Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02073.X

10.1111/J.1538-7836.2006.02073.X

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018